A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: A University of Rochester Cancer Center Community Clinical Oncology Program research base study

Cancer

Volumn 116, Issue 14, 2010, Pages 3513-3520

  Jean Pierre, Pascal ^a,b   Morrow, Gary R ^b   Roscoe, Joseph A ^b   Heckler, Charles ^b   Mohile, Supriya ^b   Janelsins, Michelle ^b   Peppone, Luke ^b   Hemstad, Amy ^c   Esparaz, Benjamin T ^d   Hopkins, Judith O ^e  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c Metro Minnesota Community Clinical Oncology Program   (United States)

^d Central Illinois Community Clinical Oncology Program   (United States)

^e SCCC Community Clinical Oncology Program   (United States)

Author keywords

Behavioral oncology; Cancer; Cancer side effects; Cancer related fatigue; Chemotherapy; Symptom management

Indexed keywords

MODAFINIL;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RELATED FATIGUE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SELF REPORT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLACEBOS;

EID: 77954911792     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25083     Document Type: Article

References (28)

1. Curran SL, Beacham AO, Andrykowski AM. Ecological momentary assessment of fatigue following breast cancer treatment. J Behav Med. 2004;27:425-444.
2. Schwartz AL, Nail LM, Chen S, et al. Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest. 2000;18:11-19.
3. Jean-Pierre P, Figueroa-Moseley C, Kohli S, Fiscella K, Palesh O, Morrow GR. Assessment of cancer related fatigue: implications for clinical diagnosis and treatment. Oncologist. 2007;12(suppl 1):11-21.
4. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640-650.
5. Gaston-Johansson F, Fall-Dickson JM, Bakos AB, et al. Fatigue, pain and depression in pre-autologous breast cancer patients. Cancer Pract. 1999;7:240-247.
6. Hofman M, Morrow GR, Roscoe JA, et al. Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center - Community Clinical Oncology Program Study of 938 patients from community practices. Cancer. 2004;101:851-857.
7. Jacobsen PB, Hann DM, Azzarello LM, et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course and correlates. J Pain Symptom Manage. 1999;19:14-27.
8. Maughan TS, James RD, Kerr DJ, et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomized trial. Lancet. 2000;359:1555-1563.
9. Mock V, Abernathy AP, Atkinson A, et al. NCCN clinical practice guidelines in oncology: cancer-related fatigue v. 1.2006. Jenkintown, PA: National Comprehensive Cancer Network, 2006. Available at: www.nccn.org/ professionals/ physician-gls/PDF/fatigue.pdf. Accessed April 15, 2010.
10. Morrow GR, Hickok JT, Andrews PL, Stern RM. Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea? Psychophysiology. 2002;39:491-495.
11. Morrow GR, Andrews PL, Hickok JT, et al. Fatigue associated with cancer and its treatment. Support Care Cancer. 2002;10:389-398.
12. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer Inst. 2008;100:1155-1166.
13. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychological Bulletin. 2008:134:700-741.
14. Morrow GR, Shelke AR, Roscoe JA, et al. Management of cancer-related fatigue. Cancer Invest. 2005;23:229-239.
15. Cleeland CS. Measurement of pain by subjective report. In: Chapman CR, Loeser JD, eds. Issues in Pain Measurement. New York, NY: Raven Press; 1989:391-403.
16. Shi Q, Wang XS, Mendoza TR, Pandya KJ, Cleeland CS. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009;37:168-174.
17. Morrow GR, Gillies LJ, Hickok JT, Roscoe JA, Padmanaban D, Griggs JJ. The positive effect of the psychostimulant modafinil on fatigue from caner that persists after treatment is completed [abstract]. J Clin Oncol. 2005;23(16 suppl):8012.
18. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
19. Anonymous. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology. 2000;54:1166-1175.
20. Norcross JC, Guadagnoli E, Prochaska JO. Factor structure of the Profile of Mood States (POMS): two partial replications. J Clin Psychol. 1984;40:1270-1277. (Pubitemid 14002232)
21. Roscoe JA, Morrow GR, Hickok JT, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res. Treat. 2005;89:243-249.
22. Rubin DB. Inference and missing data. Biometrika. 1976;63:581-590.
23. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85:1186-1196.
24. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory. Cancer. 2000;89:1634-1646.
25. Chang YJ, Lee JS, Lee CG, et al. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007;15:891-896.
26. Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors [abstract]. J Clin Oncol. 2006;24(18 suppl). Abstract 1503.
27. Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21:4635-4641.
28. Sloan JA, Berk L, Roscoe J, et al. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007;25:5070-5077.